bioMérieux

Oxford Nanopore Technologies has transformed DNA and RNA analysis through portable, real-time sequencing systems ranging from MinION to the high-throughput PromethION platform. Revenue reached £223.9 million in 2025, but slower first-half growth, declining liquid resources and full-year guidance that includes some non-recurring collaboration and licensing income have kept profitability under scrutiny.